Akèy › Metiyè › Molecular and Cellular Biologists › Mountain View, CA
Molecular and Cellular Biologists nan Mountain View, CA: Salè H-1B
21 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Mountain View, CA. Salè baz medyàn ofri $111,488; mwatye mitan $84,989–$167,895.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $84,989 |
| Nivo II (kalifye) | $108,285 |
| Nivo III (eksperyans) | $168,375 |
| Nivo IV (plen kompetans) | $181,772 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Dnanexus, Inc. | 4 | $167,750 |
| Michigan State University | 2 | $77,742 |
| ImpriMed, Inc. | 2 | — |
| Google LLC | 2 | $186,000 |
| MetaNovas Biotech | 2 | $84,989 |
| Atila BioSystems, Inc. | 1 | $84,000 |
| Mineral Earth Sciences LLC | 1 | $218,000 |
| Thermo Fisher Scientific Inc. | 1 | $108,285 |
| Epimeron USA | 1 | $80,000 |
| Immucor, Inc. | 1 | $102,600 |
| Danisco US Inc. | 1 | $114,691 |
| PTC Therapeutics, Inc. | 1 | $95,200 |
| Alive Inc. | 1 | $167,943 |
| Rococobio Unus, Inc. | 1 | — |
Tit travay
- Data Resource Analyst II2
- Sr. Bioinformatics Scientist2
- Senior Research Associate2
- Bioinformatics Data Analyst2
- Principal Bioinformatics Scientist2
- Associate Scientist1
- Technical Program Manager (Computational Biologist)1
- Scientist III, Bioinformatics1
- Clinical Specialist1
- Scientist1
- Computational Biologist1
- Bioinformatics Scientist1
- Scientist II1
- Associate Scientist II, Multiomics Analysis1
- Biological Researcher1
Pwonse H-1B nan Mountain View, CA →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).